Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Simons

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
European Urology|January 1, 1994
Gene therapy in urological oncology: principles, strategies and potentialS F Brewster, J W Simons
Cancer Treatment and Research|January 1, 1996
Renal, bladder, and prostate cancers: gene therapyM A Carducci, J W Simons
Somatic Cell Genetics|May 1, 1982
Phenotypic drug resistance in mammalian cells in vitroP C Verschure, J W Simons
Urology|October 1, 1994
Gene therapy for urologic cancerM G Sanda, J W Simons
Mutation Research|June 1, 1987
Mutagen-sensitive cell lines are obtained with a high frequency in V79 Chinese hamster cellsM Z Zdzienicka, J W Simons
The Urologic Clinics of North America|April 8, 1998
The future of gene therapy in the treatment of urologic malignanciesJ W Simons, F F Marshall
Cancer Treatment Reviews|July 1, 1993
Systemic therapy of prostate cancer. New concepts from prostate cancer tumor biologyW S Hsieh, J W Simons
Mutation Research|May 1, 1979
Mutagenicity of 8-methoxypsoralen and long-wave ultraviolet irradiation in V-79 Chinese hamster cells. A first approach to a risk estimate in photochemotherapyP M Burger, J W Simons
Mutation Research|October 1, 1975
A mutational assay system for L5178Y mouse lymphoma cells, using hypoxanthine-guanine-phosphoribosyl-transferase (HGPRT) -deficiency as marker. The occurrence of a long expression time for mutations induced by X-rays and EMSA G Knaap, J W Simons
The Urologic Clinics of North America|November 1, 1996
New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomyW G Nelson, J W Simons
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
European Urology|January 1, 1994
Gene therapy in urological oncology: principles, strategies and potentialS F Brewster, J W Simons
Cancer Treatment and Research|January 1, 1996
Renal, bladder, and prostate cancers: gene therapyM A Carducci, J W Simons
Somatic Cell Genetics|May 1, 1982
Phenotypic drug resistance in mammalian cells in vitroP C Verschure, J W Simons
Urology|October 1, 1994
Gene therapy for urologic cancerM G Sanda, J W Simons
Mutation Research|June 1, 1987
Mutagen-sensitive cell lines are obtained with a high frequency in V79 Chinese hamster cellsM Z Zdzienicka, J W Simons
The Urologic Clinics of North America|April 8, 1998
The future of gene therapy in the treatment of urologic malignanciesJ W Simons, F F Marshall
Cancer Treatment Reviews|July 1, 1993
Systemic therapy of prostate cancer. New concepts from prostate cancer tumor biologyW S Hsieh, J W Simons
Mutation Research|May 1, 1979
Mutagenicity of 8-methoxypsoralen and long-wave ultraviolet irradiation in V-79 Chinese hamster cells. A first approach to a risk estimate in photochemotherapyP M Burger, J W Simons
Mutation Research|October 1, 1975
A mutational assay system for L5178Y mouse lymphoma cells, using hypoxanthine-guanine-phosphoribosyl-transferase (HGPRT) -deficiency as marker. The occurrence of a long expression time for mutations induced by X-rays and EMSA G Knaap, J W Simons
The Urologic Clinics of North America|November 1, 1996
New approaches to adjuvant therapy for patients with adverse histopathologic findings following radical prostatectomyW G Nelson, J W Simons
Pageof 14